TR200501513T3 - Tesadüfi ajanların saptanmasında ribozimlerin kullanılması. - Google Patents

Tesadüfi ajanların saptanmasında ribozimlerin kullanılması.

Info

Publication number
TR200501513T3
TR200501513T3 TR2005/01513T TR200501513T TR200501513T3 TR 200501513 T3 TR200501513 T3 TR 200501513T3 TR 2005/01513 T TR2005/01513 T TR 2005/01513T TR 200501513 T TR200501513 T TR 200501513T TR 200501513 T3 TR200501513 T3 TR 200501513T3
Authority
TR
Turkey
Prior art keywords
ribozymes
detect random
agents
random agents
indicator cells
Prior art date
Application number
TR2005/01513T
Other languages
English (en)
Turkish (tr)
Inventor
C. Coffey Matthew
Original Assignee
Oncolytics Biotech, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oncolytics Biotech, Inc. filed Critical Oncolytics Biotech, Inc.
Publication of TR200501513T3 publication Critical patent/TR200501513T3/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/04Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C12N15/1131Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against viruses
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701Specific hybridization probes
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983Viruses
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00Structure or type of the nucleic acid
    • C12N2310/10Type of nucleic acid
    • C12N2310/12Type of nucleic acid catalytic nucleic acids, e.g. ribozymes
    • C12N2310/121Hammerhead
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2521/00Reaction characterised by the enzymatic activity
    • C12Q2521/30Phosphoric diester hydrolysing, i.e. nuclease
    • C12Q2521/337Ribozyme
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08RNA viruses
    • G01N2333/14Reoviridae, e.g. rotavirus, bluetongue virus, Colorado tick fever virus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Hematology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Urology & Nephrology (AREA)
  • General Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Plant Pathology (AREA)
  • Toxicology (AREA)
  • Oncology (AREA)
TR2005/01513T 2002-02-28 2003-02-26 Tesadüfi ajanların saptanmasında ribozimlerin kullanılması. TR200501513T3 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US36073002P 2002-02-28 2002-02-28

Publications (1)

Publication Number Publication Date
TR200501513T3 true TR200501513T3 (tr) 2005-06-21

Family

ID=27766245

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2005/01513T TR200501513T3 (tr) 2002-02-28 2003-02-26 Tesadüfi ajanların saptanmasında ribozimlerin kullanılması.

Country Status (16)

Country Link
EP (2) EP2439286A1 (enExample)
JP (3) JP4369243B2 (enExample)
AR (1) AR038849A1 (enExample)
AT (1) ATE519860T1 (enExample)
AU (1) AU2003206587B2 (enExample)
BR (1) BR0307882A (enExample)
CA (1) CA2374388C (enExample)
DE (1) DE03704136T1 (enExample)
DK (1) DK1481084T3 (enExample)
ES (1) ES2241506T3 (enExample)
MX (1) MXPA04008277A (enExample)
NZ (1) NZ534488A (enExample)
TR (1) TR200501513T3 (enExample)
TW (1) TWI329132B (enExample)
WO (1) WO2003072811A2 (enExample)
ZA (1) ZA200406231B (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1306959C (zh) * 2004-09-21 2007-03-28 中国科学院武汉病毒研究所 草鱼呼肠孤病毒抗原亚单位疫苗制备方法
CA2617600A1 (en) 2005-08-01 2007-09-07 University Technologies International, Inc. Attenuated reovirus
US10668119B2 (en) 2005-08-01 2020-06-02 Virocure, Inc. Attenuated reovirus
US10369171B2 (en) 2007-03-13 2019-08-06 Virocure, Inc. Attenuated reoviruses for selection of cell populations
TW201738562A (zh) * 2009-05-28 2017-11-01 亞培生物股份有限公司 體外病原體檢驗技術

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4987071A (en) 1986-12-03 1991-01-22 University Patents, Inc. RNA ribozyme polymerases, dephosphorylases, restriction endoribonucleases and methods
US5254678A (en) 1987-12-15 1993-10-19 Gene Shears Pty. Limited Ribozymes
US5168053A (en) 1989-03-24 1992-12-01 Yale University Cleavage of targeted RNA by RNAase P
US5225347A (en) 1989-09-25 1993-07-06 Innovir Laboratories, Inc. Therapeutic ribozyme compositions and expression vectors
US5225337A (en) 1989-09-25 1993-07-06 Innovir Laboratories, Inc. Ribozyme compositions and methods for use
US5631115A (en) 1992-07-02 1997-05-20 Sankyo Company, Limited Looped, hairpin ribozyme
EP0707638A4 (en) * 1992-12-04 1998-05-20 Innovir Lab Inc REGULATABLE THERAPEUTIC NUCLEIC ACID AND METHOD FOR THE USE THEREOF
ATE199568T1 (de) 1993-02-16 2001-03-15 Onyx Pharma Inc Cytopatische viren zur therapie und prophylaxe der neoplasie
EP1314431B1 (en) 1993-04-30 2008-07-16 Wellstat Biologics Corporation Purified compositions of Newcastle disease virus
WO1995010608A1 (en) * 1993-10-15 1995-04-20 Foundation For Research And Technology - Hellas (Fo.R.T.H.) Asymmetric hammerhead ribozymes and nucleotide sequences for their construction
US5631359A (en) 1994-10-11 1997-05-20 Ribozyme Pharmaceuticals, Inc. Hairpin ribozymes
US6107027A (en) * 1994-12-14 2000-08-22 University Of Washington Ribozymes for treating hepatitis C
US6136307A (en) 1997-08-13 2000-10-24 Oncolytics Biotech Inc. Reovirus for the treatment of cellular proliferative disorders
US6110461A (en) * 1997-08-13 2000-08-29 Oncolytics Biotech Inc. Reovirus for the treatment of neoplasia
NZ503664A (en) 1997-10-09 2002-08-28 Pro Virus Inc A method for purifying an RNA virus comprising generating a clonal virus and purifying the clonal virus by ultracentrifugation without pelleting
WO1999050277A1 (en) 1998-03-28 1999-10-07 University Of Utah Research Foundation Circular, hairpin, circular/hairpin, lariat, and hairpin-lariat hammerhead ribozymes
WO2000024912A1 (en) * 1998-10-23 2000-05-04 The Children's Medical Center Corporation Use of a self-cleaving rna motif to modulate gene expression
WO2001072964A2 (en) * 2000-03-27 2001-10-04 Smithkline Beecham Corporation Detection of viable agents
TWI289158B (en) 2000-08-10 2007-11-01 Oncolytics Biotech Inc Method of producing infectious reovirus

Also Published As

Publication number Publication date
MXPA04008277A (es) 2004-11-10
ATE519860T1 (de) 2011-08-15
JP5615865B2 (ja) 2014-10-29
ES2241506T3 (es) 2011-12-13
JP2012125257A (ja) 2012-07-05
DK1481084T3 (da) 2011-09-26
ZA200406231B (en) 2005-11-30
EP2439286A1 (en) 2012-04-11
ES2241506T1 (es) 2005-11-01
TW200404099A (en) 2004-03-16
WO2003072811A2 (en) 2003-09-04
JP4369243B2 (ja) 2009-11-18
WO2003072811A3 (en) 2004-02-05
EP1481084B1 (en) 2011-08-10
AU2003206587A1 (en) 2003-09-09
AR038849A1 (es) 2005-01-26
JP2005518797A (ja) 2005-06-30
TWI329132B (en) 2010-08-21
AU2003206587B2 (en) 2007-03-15
HK1067664A1 (en) 2005-04-15
NZ534488A (en) 2008-04-30
EP1481084A2 (en) 2004-12-01
CA2374388C (en) 2005-07-12
BR0307882A (pt) 2004-12-28
JP2009005712A (ja) 2009-01-15
CA2374388A1 (en) 2003-08-28
DE03704136T1 (de) 2005-12-15

Similar Documents

Publication Publication Date Title
NO20051921L (no) Fotoprotein med forbedret bioluminescens
DK1067384T3 (da) Prøvedetektion for at igangsætte tidsmålingen i en elektrokemisk test
AU1461702A (en) Microvolume immunoabsorbant assays with amplified electrochemical detection
BRPI0412217A (pt) método de avaliação da eficácia de anticorpo, métodos de imunoterapia, método de detecção de anticorpos neutralizantes a anticorpo terapêutico e método de avaliação da eficácia de antagonista
WO2002066671A3 (en) Improved method for detection of atp
ATE372289T1 (de) Messstreifenspenderanordnung
MX336070B (es) Eventos de alfalfa tolerantes a glifosato y metodos para su deteccion.
ATE489469T1 (de) Maize kompositionen mit erhöhtem lysine gehalt und methoden zu deren detektion
TW200616578A (en) Fluid handling devices
IL151674A0 (en) Method for detecting an analyte by fluorescence
ATE279531T1 (de) Test zum nachweis der aktivität von phospho-n- acetylmuramyl-pentapeptid-translokase
DE60124975D1 (de) Automatischer apparat zum messen von wassertoxizität
EP1381864A4 (en) DETECTION OF CANDIDA
MY131964A (en) 2-amino-2-alkyl-5 heptenoic and heptynoic acid derivatives useful as nitric oxide synthase inhibitors
MXPA02001307A (es) Deteccion de micro-organismos.
WO2004094675A3 (en) Compositions and methods for determining the presence of sars coronavirus in a sample
DE602005016800D1 (de) Hif-prolylhydroxylase-aktivitätstest
AR058959A1 (es) Metodos para modular receptores de la superficie celular para prevenir o reducir la inmflamacion
TR200501513T3 (tr) Tesadüfi ajanların saptanmasında ribozimlerin kullanılması.
WO2003081253A3 (en) Electrochemical multi-well plate
WO2002059600A3 (en) Analyte detection
DE60100388D1 (de) Aminosäurederivate und deren verwendung als inhibitoren von nep, ace und ece
ATE406461T1 (de) Rna-bioassay
DE602004015629D1 (de) Ansfertest
DE60327776D1 (de) Sonden zum nachweis von tumorzellen